Inflammation plays a pivotal role in both physiological adaptation and pathological processes. Inflammation is the response of living vascularized tissue to injury and can be triggered by microbial infections, physical agents, chemical substances, necrotic tissue, or immunological reactions. The goal of inflammation is to contain and isolate the injury, destroy invading microorganisms, and inactivate toxins, as well as prepare the tissue for healing and repair (1).Conversely, chronic low-grade inflammation is defined as a two to four-fold elevation in circulating pro-inflammatory markers, including C-reactive protein (CRP), tumor necrosis factor-a (TNFa), and interleukin-6 (IL-6). This persistent inflammatory state is strongly associated with the aging process and contributes mechanistically to sarcopenia-the age-related reduction in muscle mass and strength (2). Beyond aging, inflammation drives the progression of several chronic diseases: elevated CRP and TNF-a concentrations are associated with increased total knee pain in osteoarthritis, and chronic inflammation can lead to metabolic disorders such as Type 2 Diabetes Mellitus and cardiovascular diseases. However, the increase in IL-6 following exercise may play a beneficial role by mobilizing substrates for energy and enhancing insulin sensitivity, potentially protecting against disorders like Type 2 Diabetes Mellitus by inhibiting TNF-a production (3). The clinical and performance implications of managing inflammation are critical, as exercise-induced muscle trauma results in pain, delayed onset muscle soreness (DOMS), reduced range of motion, and prolonged muscle strength loss, negatively impacting subsequent athletic performance (4,5). With this in mind, pharmacological and nonpharmacological interventions have gained attention for improving quality of life by enhancing cardiovascular, metabolic, and inflammatory parameters (6)(7)(8)(9).In this context, creatine is a widely popular dietary supplement utilized as an ergogenic aid. Its well-established performanceenhancing effects are rooted in its fundamental role as a temporal and spatial energy buffer. Supplementation reliably increases total muscle creatine concentration, enhancing phosphocreatine (PCr) availability to facilitate ATP resynthesis during high-intensity exercise (10). When combined with resistance training, creatine reliably promotes strength and fat-free mass gains in diverse populations, including older adults (11). While creatine is widely recognized for its performance-enhancing properties, recent studies suggest it may also modulate inflammatory responses, especially following intense physical activity. Creatine is reported to be anti-inflammatory in nature, helping to maintain muscle integrity and attenuating inflammatory markers after strenuous exercise sessions (4,12).The precise mechanisms underlying creatine's antiinflammatory and cytoprotective effects remain to be definitively determined. However, several mechanisms have been proposed. One theory involves osmotic effects and cellular swelling; creatine increases intracellular water content (13).Current evidence regarding creatine's potential antiinflammatory properties remains inconsistent, highlighting significant knowledge gaps across different populations and protocols. Positive effects in athletes subject to high physiological stress have been frequently reported. For instance, creatine supplementation for five days prior to a half-ironman competition significantly reduced the exercise-induced increase in plasma levels of pro-inflammatory cytokines, including TNF-a, interferon-alpha (IFN-a), and interleukin-beta (IL-1b), as well as Prostaglandin E2 (PGE2), 24 and 48 hours post-competition (4,12). Similarly, creatine supplementation attenuated the post-race increase in plasma TNF-a (by 33.7%) and PGE2 (by 60.9%), and abolished the increase in lactate dehydrogenase (LDH) activity following a strenuous 30 km race in marathon runners (4,12). However, null findings have limited the generalization of these effects to other populations or exercise types. In studies focused on chronic, low-grade inflammation, 12 weeks of creatine supplementation yielded no effect on inflammatory biomarkers (CRP, IL-1b, IL-6, TNF-a) in patients with mild to moderate knee osteoarthritis (14). Moreover, combining creatine supplementation (5 g/day for 12 weeks) with resistance training in community-dwelling older adults failed to provide additional benefits on systemic inflammation markers such as IL-6, interleukin 10 (IL-10), and CRP, compared to training with placebo (15). Creatine also failed to reduce muscle damage (assessed via strength, range of motion, soreness, and elevated creatine kinase activity) or enhance recovery following a resistance exercise challenge designed to be hypoxic in trained men (5). Several methodological limitations contribute to these discrepancies, as many studies are small-scale; for example, the study investigating creatine in osteoarthritis included only 18 participants (14) and the half-ironman study included only 11 triathletes (4,5). Furthermore, the inflammatory markers assessed vary widely across trials, ranging from cytokines (IL-6, TNF-a, IL-1b, IFN-a) and pain mediators (PGE2) to muscle damage proxies (creatine kinase-CK, lactate dehydrogenase-LDH, CRP). Despite growing interest, current evidence on creatine's impact on inflammation remains fragmented, with no consensus across populations or protocols.The inconsistencies observed between trials that investigated acute exercise-induced inflammation (4,12) and those addressing chronic inflammation (14,15) highlight a critical need for synthesizing the accumulated data (14). A systematic synthesis and meta-analysis is therefore warranted to rigorously aggregate findings from randomized controlled trials. Such an approach will permit a detailed evaluation of acute versus chronic creatine effects across different physiological states and population subsets (5). Crucially, this effort must focus on objective inflammatory markers measured in human participants to clarify the clinical and physiological relevance of creatine's purported antiinflammatory effects. A systematic review with meta-analysis is warranted to clarify whether creatine exerts clinically meaningful anti-inflammatory effects in humans, particularly in the context of exercise-induced and chronic inflammation.Therefore, the present study aimed to systematically review and meta-analyze randomized controlled trials investigating the effects of creatine supplementation on inflammatory biomarkers in humans. We hypothesized that creatine would reduce levels of key inflammatory markers, particularly in response to acute exercise-induced stress (4,12).The review followed the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and and been in the studies from and from the of to The in the the of and of The included the following a a a in the to for and in by two followed by In of a the the the whether a meta-analysis on study and exercise and in a from When no response data only in as and When studies reported or these to data to inflammatory biomarkers to between and regarding and from the included that or reported from of assessed the of in The as or the and by a prior training in of the study and review such as and also of evidence the of and approach included study methodological of and across studies The to the of and findings in and with on cardiovascular and inflammatory in both and two studies a the as of effects as with In biomarkers measured on across studies different or in The in the with A to methodological and clinical to whether trials a on the effect particularly by in the effect after of studies or of the trials. This to the and of the In to creatine chronic to potential of the acute effects the a physiological response to a This included studies that or both of the following Supplementation The creatine defined as a days of with the measured The inflammatory measured or hours following an acute exercise of the total the the a physiological adaptation or This both of the following Supplementation The creatine a followed by a The levels of inflammatory markers, training the of the supplementation training with no acute exercise the meaningful or a of two studies data to the The of trials to these be for those total of to the the of and studies for of be The studies assessed for studies for the following data population 18 of a review study no placebo and no of reported studies included in the The and study process in with the as in focused on the impact of creatine supplementation on inflammatory The studies effects on the population and reported that creatine supplementation g/day for significantly attenuated inflammatory following a race in creatine reduced post-race increases in 2 2 by and tumor necrosis factor-a by a effect against muscle damage and systemic Similarly, a g/day for that creatine supplementation in triathletes to significantly levels of TNF-a, (IL-1b), and 2 after a findings the anti-inflammatory potential of creatine during prolonged and intense potentially via of to physiological several studies failed to such benefits in other and (14) creatine supplementation g/day for followed by g/day for 11 weeks) to patients with mild to moderate knee osteoarthritis and no significant in inflammatory markers, including CRP, IL-1b, IL-6, and This that creatine may anti-inflammatory effects in chronic low-grade inflammatory Similarly, a randomized in older adults a of of creatine combined with resistance The results no significant between the creatine and placebo in key inflammatory markers such as IL-6, or CRP, both in a potential effect of training investigated the effects of creatine the in men after days of supplementation combined with acute resistance observed increases in of such as and no effect of creatine on IL-6 that creatine inflammatory in muscle tissue these creatine's effects on recovery from hypoxic resistance exercise in trained men a supplementation and reported no reduction in markers of muscle damage or lactate dehydrogenase CRP increased following the exercise and creatine no effect on recovery these findings to an older population of resistance In this creatine (5 combined with in significant in IL-6 or CRP levels compared to observed in and strength This a potential between and systemic inflammatory reported that creatine supplementation g/day for well in athletes a the that no effects observed during the supplementation or the race muscle or and participants the race performance findings that acute creatine clinically of prolonged and strenuous Similarly, an supplementation g/day for reported no clinical in trained triathletes in a or during the or the post-race the of creatine supplementation in the context of physiological several studies in clinical or aging populations also reported a and creatine supplementation g/day for followed by g/day for 11 weeks) to patients with mild to moderate knee osteoarthritis and reported no the of or systemic markers and creatine associated with or inflammatory the effects of creatine supplementation (5 g/day for 12 weeks) combined with resistance training in older adults and no evidence of metabolic or inflammatory effects. The reported no in insulin or circulating inflammatory that creatine and well in this older population combined with investigated the effects of creatine supplementation g/day for in men acute resistance exercise with muscle Despite the of the and the high supplementation no or to creatine reported. The of reported effects of creatine in controlled Similarly, of in supplementation 10 days in men and no increase in muscle soreness, or markers of muscle injury or systemic The also that regarding muscle for acute effects of creatine on C-reactive for chronic effects of creatine on C-reactive protein and interleukin-6 of by the of creatine supplementation in resistance exercise to a in older adults of resistance Creatine supplementation (5 combined with in a increase in plasma and effects observed in creatine kinase or systemic inflammatory markers such as IL-6 and C-reactive results suggest that creatine supplementation is in older adults moderate and exercise the acute effects of creatine supplementation on CRP, two trials included The no significant between creatine and placebo The in study results a effect reported a increase in IL-6 placebo The meta-analysis the chronic effects of creatine supplementation on CRP included two randomized controlled trials with a combined of participants a the no significant between creatine and placebo high across studies trials, reported an of a of effect these findings that chronic creatine supplementation significantly concentrations compared with placebo The meta-analysis chronic effects of creatine on IL-6 also included two studies with a total of The no significant between creatine and placebo findings across trials (14) reported no between a reduction in of creatine results that chronic creatine supplementation CRP levels the evidence an acute effect of creatine supplementation on IL-6 to of involves a or like or in this This with the current methodological by the for Systematic Reviews of The strongly a of studies to the of these of across the included with in several including from and of reported the studies a of and high of studies the process and as for this to have been with no evidence of or systematic between the of to from interventions to be studies or the that or of the interventions the in and or The studies reported or for that to have the studies as for this and for the of in studies and regarding as or of that the quality of evidence regarding the effects of creatine supplementation on inflammatory markers limited by to of the of and and across However, the of data to a of of for CRP CRP IL-6 for these including of data and study are in the moderate observed studies inflammatory may be to methodological and clinical in supplementation from to several trained athletes versus older and exercise versus resistance Moreover, trials provide detailed or to potentially the of observed effects. Despite these discrepancies, the of the results a potential anti-inflammatory effect of creatine supplementation different systematic review with meta-analysis aimed to the effects of creatine supplementation on inflammatory markers in human key observed Creatine supplementation reduce biomarkers associated with chronic low-grade inflammation, CRP or IL-6, across diverse clinical or For instance, plasma IL-6 concentrations significantly by creatine supplementation after an competition creatine resistance training provide additional benefits on IL-6 or CRP in older adults compared to resistance training While trials in athletes high physiological results or in older adults and clinical In creatine failed to reduce muscle damage markers like or muscle soreness following hypoxic resistance exercise in trained of evidence for chronic markers in populations and of present in several anti-inflammatory effects of creatine to be strongly on the physiological context in supplementation is One of the mechanisms is to cytoprotective effects on muscle Creatine increases muscle intracellular water This may increase muscle resistance to injury, and the inflammatory process as a studies that creatine supplementation abolished the increase in a anti-inflammatory creatine to inflammatory associated with and metabolic such as prolonged limited in by chronic, low-grade inflammation in creatine's cytoprotective role the cellular during acute muscle Creatine increases intracellular water and resistance to damage This effect may reduce and subsequent the of that acute inflammatory with this studies reported that creatine supplementation abolished or attenuated increases in a of cellular following high-intensity and competition stress In creatine may modulate inflammatory during acute stress by attenuating the production or of pro-inflammatory studies have in circulating TNF-a, IL-1b, and 2 following strenuous exercise in athletes (4,12). effects may be by in cellular energy and as in evidence that creatine can reduce of potentially to in ATP and phosphocreatine availability these mechanisms may be to chronic low-grade inflammation, is by systemic including tissue and In such inflammatory activity is triggered by acute tissue and to interventions muscle integrity or inflammatory (2). This may creatine supplementation failed to reduce markers such as CRP and IL-6 in populations with knee osteoarthritis or in older prolonged supplementation creatine properties that contribute to anti-inflammatory effects these in the context of chronic systemic the evidence the that creatine as a cytoprotective and anti-inflammatory inflammatory to high-intensity physiological as a of chronic inflammatory This is critical for the findings across trials and for of creatine's anti-inflammatory potential the in it is and findings the that the anti-inflammatory effects of creatine are beneficial effects is to physiological In athletes to creatine attenuated increases in inflammatory including TNF-a and 2 after a 30 km race as well as TNF-a, and following a competition findings suggest that creatine may inflammation to muscle damage and metabolic a antiinflammatory this to by chronic low-grade inflammation or to resistance exercise that systemic inflammatory In clinical populations with knee osteoarthritis, 12 weeks of creatine supplementation failed to inflammatory biomarkers or markers (14). Similarly, in older creatine combined with resistance training provide additional in inflammatory markers or insulin resistance those by training (15). Moreover, creatine markers of muscle damage or inflammation following hypoxic resistance that its effects observed in to muscle damage these findings that creatine's antiinflammatory potential is the and of the physiological Creatine in attenuating inflammation from it limited or no in chronic inflammatory states or resistance exercise with systemic inflammatory This a for the results across trials and with the findings of the present systematic review and on across populations, beneficial effects are to trained athletes to exercise In these creatine significantly attenuated exercise-induced increases in cytokines and PGE2 following both a competition and a race (4,12). In studies in clinical populations or older by low-grade inflammation, reported null weeks of creatine supplementation CRP, IL-6, TNF-a, IL-1b, or levels in with knee osteoarthritis creatine combined with resistance training systemic inflammatory markers in community-dwelling older exercise-induced in this in mind, exercise this context effects observed in or that metabolic and stress resistance exercise designed to muscle such as hypoxic or in muscle damage or inflammatory markers with creatine supplementation compared with placebo (5). This that creatine's effects are across exercise supplementation to be a critical g/day for five days a strenuous in inflammatory in (4,12). In chronic g/day for 12 weeks) failed to reduce systemic markers of chronic inflammation such as CRP and IL-6 these findings the that creatine as a cytoprotective against exercise-induced tissue as a of chronic low-grade a meta-analysis focused on key chronic markers and the effect would be as and In a the the of the effect across studies different the range the effect by the the of total in study that is to in the effects between is the for as on the of studies CRP and on CRP and IL-6 across chronic studies would no significant effect of creatine supplementation the null findings for these markers in chronic, inflammatory the for these would be from The a of chronic effect may from studies focused on acute (4,12). This meta-analysis populations and For instance, creatine significantly reduced TNF-a, IL-1b, and PGE2 in triathletes effects that are to muscle trauma However, these effects are with data from older adults inflammation is to metabolic exercise the effect on systemic markers like IL-6 and CRP of the evidence as to This is to data and the across trials. included studies in in the half-ironman study in the study studies and and of limitations (14). For example, the study on knee osteoarthritis patients limited by its may have the to significant in results also limited the findings of creatine as an anti-inflammatory is by to athletes in creatine supplementation benefits in acute exercise-induced inflammation, muscle damage and pain mediators (PGE2) following (4,12). creatine is a for muscle integrity and recovery in this population to older adults or those with chronic Creatine is as an to reduce chronic inflammatory markers (CRP, IL-6, TNF-a) in like knee osteoarthritis or aging While creatine combined with resistance training significant benefits in improving fat-free mass and strength in older adults the hypothesized anti-inflammatory to reliably in chronic must be to the results observed in acute exercise to chronic on this the null findings observed in the be as evidence that creatine clinical or that its effects are to as meaningful in systemic inflammatory biomarkers in chronic In populations by persistent inflammation, such as older adults or with osteoarthritis, the of effect on CRP or IL-6, to be and well clinically in these biomarkers may contribute to in the evidence that creatine supplementation is to such and therefore be as a anti-inflammatory in these a clinical these findings that creatine's in older or clinical populations be its well-established benefits on muscle strength, and of systemic inflammation in physical and exercise may inflammatory these effects are by in CRP or and be in anti-inflammatory acute exercise and creatine for its and benefits patients or older performance and the of a effect in the relevance of creatine during of physiological it that creatine's anti-inflammatory is inflammation is to acute muscle damage and metabolic In this context, in inflammatory mediators or muscle damage markers may have meaningful implications for training and competition in inflammatory biomarkers for several that a clinically meaningful reduction in systemic inflammation is are and inconsistent, and remain clinically for For chronic and effects with and no moderate or While studies the null findings across populations, combined with to suggest effect is of the evidence from the high in study different populations, physiological and protocols. The included trials from athletes strenuous exercise to older adults in with chronic such as osteoarthritis or and in inflammatory metabolic muscle and to supplementation and to creatine supplementation is to be and the observed effects may be by underlying activity or metabolic the included studies only in population also in methodological such as creatine and of supplementation to and the or of resistance or training the inflammatory biomarkers assessed across trials, with studies acute and on chronic markers such as CRP or methodological additional of that between may have reduced the and of the as the underlying mechanisms and of effect across these diverse clinical and physiological For instance, creatine may modulate inflammatory in an compared to an with chronic low-grade inflammation, the approach these effects. a the effect be with as may meaningful or potential benefits only This the need for to by population inflammatory and to effects of creatine in trials from subject to meaningful the half-ironman study 11 total triathletes studies inflammatory markers While studies many focused only on or two markers or potentially effects (5). is a of trials in clinical The of trials to in clinical it to the impact of creatine on progression (14). is also an of protocols. The of across creatine in with the potential effect of the in the by two methodological and with studies The inflammatory reported in this CRP and IL-6, with findings from other included trials that creatine studies failed to significant in systemic inflammatory This across trials the that supplementation a clinically meaningful antiinflammatory effect of creatine in the and the the or of the to the of the the study in the that its findings be as the effects of creatine in the of a context creatine these that the potential anti-inflammatory effects of controlled the and the of the present meta-analysis regarding the impact of creatine on systemic inflammatory synthesis of evidence is significantly by in study populations and activity widely from trained such as triathletes and marathon runners to older adults (14) or patients The across these studies from men to 10 in patients Furthermore, the exercise by and acute trauma or chronic stress competition or a 30 km recovery following resistance exercise designed to be hypoxic or resistance training trials patients with no exercise training to the creatine and from acute days of prior to a competition (4,12) or a study of days to chronic supplementation 12 weeks and to 12 including of 2 or of and high of in a acute In on such as during a in and is to be a meaningful to the observed across studies and may inconsistencies between acute and chronic inflammatory by high a are to metabolic and osmotic may inflammatory markers in response to exercise or competition In supplementation may in muscle cellular and recovery potentially to different inflammatory (10). physiological between studies and the of acute and chronic interventions are to the limited of trials, these is for the findings and the need for trials designed to systematically versus on inflammatory and also Creatine in In exercise trials, after training sessions in in the study combined creatine with a the effect of of inflammatory of the antiinflammatory effects of focused on different physiological of Several studies inflammatory and muscle damage in markers like TNF-a, IL-1b, IL-6, and acute muscle damage such as and studies focused on markers associated with chronic low-grade inflammation, such as CRP, IL-6, and markers also including protein and markers of systemic stress like the Crucially, study investigated mechanisms by IL-6 and in muscle tissue via and plasma concentrations the synthesis to CRP and IL-6 the a of creatine's anti-inflammatory markers the only reported by a of studies with to However, CRP and IL-6 chronic, systemic low-grade inflammation and are to inflammatory or a the null findings that creatine supplementation is to clinically meaningful in systemic inflammatory biomarkers in chronic or populations, potential anti-inflammatory effects of markers such as TNF-a, IL-1b, and 2 for meta-analysis to the limited of studies and methodological are to acute inflammatory muscle and recovery Positive findings reported for these in trials, particularly in athletes to physiological suggest that creatine's anti-inflammatory may be and the evidence of observed for other inflammatory mediators the can be this approach that the of the meta-analysis are The of effects on CRP and IL-6 be as evidence against a systemic anti-inflammatory role for creatine in chronic for antiinflammatory or effects exercise that are by different biomarkers be is that a of via of a or such as or in this systematic This is on methodological guidelines in the for Systematic Reviews of strongly against these the of studies included for a is of a of data to that observed in the is to and or The a of included studies to with a included only two with a or would results that are and potentially Reporting such a suggest the or of the potential for as a in of to methodological by the the integrity and of must methodological to current is a need for and (14). TNF-a, CRP, on markers to the of anti-inflammatory activity on the evidence gaps and the that a cytoprotective role for trials must be rigorously designed to this the of an studies focus on creatine's cytoprotective mechanisms are to be The critical population to is trained a resistance exercise or This the tissue damage to the inflammatory that creatine is hypothesized to involves athletes in as this a of both intense metabolic and Furthermore, must markers that the of tissue damage and the inflammatory The critical are of and as for significant of is to the hypothesized cytoprotective high be to acute cytokines are in the acute following tissue must to the on markers of chronic inflammation like effect on inflammation is like a is acute by physiological stress protecting the from damage (4,12). However, it with the of chronic, low-grade inflammation associated with aging or chronic different underlying mechanisms are the the current of evidence a anti-inflammatory effect of creatine supplementation in humans, particularly regarding chronic low-grade inflammation markers such as CRP and While in athletes a reduction in exercise-induced and muscle damage these effects to older clinical populations, or supplementation The of evidence is by in and of inflammatory randomized controlled trials inflammatory supplementation and acute chronic inflammation, resistance Such methodological is to clarify whether creatine as a of acute inflammatory stress or its potential benefits to chronic inflammatory states with clinical The that for this its from the for and an to the of and from The study from and We for and in this
Building similarity graph...
Analyzing shared references across papers
Loading...
Kell Mazzini Ribeiro de Camargo
Alejandro Bruna-Mejías
Juan Jose Valenzuela-Fuenzalida
Frontiers in Immunology
SHILAP Revista de lepidopterología
University of Limerick
Fundación Ciencias Exactas y Naturales
Universidad de Costa Rica
Building similarity graph...
Analyzing shared references across papers
Loading...
Camargo et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69ddd8eee195c95cdefd6658 — DOI: https://doi.org/10.3389/fimmu.2026.1840983